Skip to main content
Fig. 2 | Renal Replacement Therapy

Fig. 2

From: Peritonitis due to Mycobacterium abscessus in peritoneal dialysis patients: case presentation and mini-review

Fig. 2

The clinical course of case 2. Horizontal axis indicates hospitalization. Line graph indicates the trend in serum C-reactive protein level. On the 1st day of admission, the exit site was red with purulent discharge (a). The dialysis effluent on the 1st day of admission had fibrin precipitation without blood (b). The PD catheter was removed on the 11th day of admission. The patient was discharged on the 135th day of admission. The patient developed encapsulating peritoneal sclerosis 16 months after the onset of peritonitis, and he was discharged 20 months after the onset of peritonitis. AMK, amikacin; CAM, clarithromycin; CAZ, ceftazidime; CEZ, cefazolin; CRP, C-reactive protein; EPS, encapsulating peritoneal sclerosis; IPM/CS, imipenem/cilastatin; MFLX, moxifloxacin; SBT/ABPC, sulbactam/ampicillin; VCM, vancomycin

Back to article page